(Q44599804)

4 December 2017

title

Insulin affects vascular smooth muscle cell phenotype and migration via distinct signaling pathways (English)

1 reference

4 December 2017

Insulin Affects Vascular Smooth Muscle Cell Phenotype and Migration Via Distinct Signaling Pathways (English)

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

15 March 2024

1 reference

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

15 March 2024

author name string

Inga Gurevich

2

1 reference

4 December 2017

Boris Draznin

3

1 reference

4 December 2017

Cecilia C. Low Wang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14514641

15 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

full work available at URL

4 December 2017

https://diabetesjournals.org/diabetes/article-pdf/52/10/2562/370276/db1003002562.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14514641

https://journals.org/diabetes/diabetes/article-pdf/52/10/2562/370276/db1003002562.pdf

15 March 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

https://diabetesjournals.org/diabetes/article-pdf/52/10/2562/370276/db1003002562.pdf

15 March 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

15 March 2024

1 reference

4 December 2017

volume

52

1 reference

4 December 2017

issue

10

1 reference

4 December 2017

page(s)

2562-2569

1 reference

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management

4 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

15 March 2024

2

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

15 March 2024

3

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

The pathogenesis of atherosclerosis: a perspective for the 1990s

15 March 2024

4

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

Cytokines and smooth muscle cells in atherosclerosis

15 March 2024

5

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

Regulation of differentiation of vascular smooth muscle cells

15 March 2024

6

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells

15 March 2024

7

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

Differentiated phenotype of smooth muscle cells depends on signaling pathways through insulin-like growth factors and phosphatidylinositol 3-kinase

15 March 2024

8

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

cAMP response element-binding protein content is a molecular determinant of smooth muscle cell proliferation and migration

15 March 2024

9

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

Actin expression in smooth muscle cells of rat aortic intimal thickening, human atheromatous plaque, and cultured rat aortic media

15 March 2024

10

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein

15 March 2024

11

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

IRS-1 activates phosphatidylinositol 3'-kinase by associating with src homology 2 domains of p85

15 March 2024

12

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction

15 March 2024

13

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats

15 March 2024

14

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle

15 March 2024

15

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells

15 March 2024

16

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

Rapid stimulation by insulin of a serine/threonine kinase in 3T3-L1 adipocytes that phosphorylates microtubule-associated protein 2 in vitro

15 March 2024

17

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF

15 March 2024

18

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

Insulin signaling in the arterial wall

15 March 2024

21

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

Wortmannin, a microbial product inhibitor of myosin light chain kinase.

15 March 2024

22

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses.

15 March 2024

23

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration

15 March 2024

26

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

Phosphatidylinositol 3-kinase inhibitors block aortic smooth muscle cell proliferation in mid-late G1 phase: effect on cyclin-dependent kinase 2 and the inhibitory protein p27KIP1

15 March 2024

27

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

Phosphatidylinositol 3-kinase signaling is important for smooth muscle cell replication after arterial injury

15 March 2024

28

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

Insulin resistance and non-insulin-dependent diabetes mellitus: cellular and molecular mechanisms

15 March 2024

29

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

15 March 2024

30

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

Plasma insulin and all-cause, cardiovascular, and noncardiovascular mortality: the 22-year follow-up results of the Helsinki Policemen Study

15 March 2024

31

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

Coronary Heart Disease Incidence and Cardiovascular Mortality in Busselton with Reference to Glucose and Insulin Concentrations

15 March 2024

32

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population

15 March 2024

33

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

Fasting insulin levels independently associated with coronary heart disease in non-diabetic Turkish men and women.

15 March 2024

34

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

Insulin and Cardiovascular Disease: Paris Prospective Study

15 March 2024

35

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly prospective study

15 March 2024

36

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

Selective insulin resistance in the polycystic ovary syndrome

15 March 2024

38

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

Insulin inhibits PDGF-directed VSMC migration via NO/ cGMP increase of MKP-1 and its inactivation of MAPKs

15 March 2024

39

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo

15 March 2024

40

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia

15 March 2024

41

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

The mitogen-activated protein kinase pathway can mediate growth inhibition and proliferation in smooth muscle cells. Dependence on the availability of downstream targets

15 March 2024

42

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2562

15 March 2024

Identifiers

1 reference

4 December 2017

1 reference